Bioresorbable vascular scaffolds — basic concepts and clinical outcome

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent

(2016) Daniel Dalos et al.   BMC Cardiovascular Disorders

Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold　– A 5-Year Serial Optical Coherence Tomography Study –

(2016) Hiroki Tateishi et al.   CIRCULATION JOURNAL

MicroRNAs for Restenosis and Thrombosis After Vascular Injury

(2016) Clarice Gareri et al.   CIRCULATION RESEARCH

Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis

(2016) Elisabetta Moscarella et al.   Circulation-Cardiovascular Interventions

Magnesium as a predictor of acute stent thrombosis in patients with ST-segment elevation myocardial infarction who underwent primary angioplasty

(2016) Gökhan Çiçek et al.   CORONARY ARTERY DISEASE

Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry

(2016) Geraud Souteyrand et al.   EUROPEAN HEART JOURNAL

Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)

(2016) Simone Biscaglia et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds

(2016) Gianluca Caiazzo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Who Is Thrombogenic: The Scaffold or the Doctor? Back to the Future! ∗

(2016) Antonio Colombo et al.   JACC-Cardiovascular Interventions

The Bioresorbable Scaffold

(2016) Hiroyoshi Kawamoto et al.   JACC-Cardiovascular Interventions

Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold

(2016) Cordula M. Felix et al.   JACC-Cardiovascular Interventions

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold

(2016) Michael J. Lipinski et al.   JACC-Cardiovascular Interventions

INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD

(2016) Jose de Ribamar Costa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis

(2016) Patrick W. Serruys et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bioresorbable Coronary Scaffold Thrombosis

(2016) Serban Puricel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Wykorzystanie stentów bioresorbowalnych Absorb BVS® u pacjentów ze stabilną chorobą wieńcową: ocena skuteczności i bezpieczeństwa leczenia hybrydowego stentów bioresorbowalnych i stentów uwalniających lek

(2016) Robert J. Gil et al.   Kardiologia Polska

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

(2016) Michael Haude et al.   LANCET

Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

(2016) Marieke L. Fokkema et al.   EuroIntervention

Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor

(2016) Annarita Carino et al.   Biomed Research International

Degree of bioresorbable vascular scaffold expansion modulates loss of essential function

(2015) Jahid Ferdous et al.   Acta Biomaterialia

Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions

(2015) Bernardo Cortese et al.   AMERICAN JOURNAL OF CARDIOLOGY

The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment

(2015) Sabato Sorrentino et al.   BMC Cardiovascular Disorders

Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry

(2015) P. Hoppmann et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Letter by De Rosa and Indolfi Regarding Article, "Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations"

(2015) S. De Rosa et al.   Circulation-Cardiovascular Interventions

Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary

(2015) Robert A. Byrne et al.   EUROPEAN HEART JOURNAL

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

(2015) Manel Sabaté et al.   EUROPEAN HEART JOURNAL

A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan

(2015) Takeshi Kimura et al.   EUROPEAN HEART JOURNAL

Absorb bioresorbable vascular scaffold: What have we learned after 5years of clinical experience?

(2015) Gianluca Caiazzo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison

(2015) Salvatore Brugaletta et al.   JACC-Cardiovascular Interventions

Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)

(2015) Yuki Ishibashi et al.   JACC-Cardiovascular Interventions

Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease

(2015) Runlin Gao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

(2015) Serban Puricel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

(2015) Patrick W Serruys et al.   LANCET

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

(2015) Stephen G. Ellis et al.   NEW ENGLAND JOURNAL OF MEDICINE

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

(2015) Alexandre Abizaid et al.   EuroIntervention

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

(2015) Jochen Wöhrle et al.   EuroIntervention

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

(2015) Robin P. Kraak et al.   EuroIntervention

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

(2015) Davide Capodanno et al.   EuroIntervention

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

(2015) Tommaso Gori et al.   EuroIntervention

Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population

(2014) Charis Costopoulos et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Neointimal Proliferation Is Associated With Clinical Restenosis 2 Years After Fully Bioresorbable Vascular Scaffold Implantation

(2014) Ciro Indolfi et al.   Circulation-Cardiovascular Imaging

Administration of a Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch From Ongoing Clopidogrel Treatment to Ticagrelor in Patients With Acute Coronary Syndrome

(2014) Gianluca Caiazzo et al.   Circulation-Cardiovascular Interventions

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'

(2014) V. Kocka et al.   EUROPEAN HEART JOURNAL

Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation

(2014) S. Silber et al.   EUROPEAN HEART JOURNAL

Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study

(2014) R. Diletti et al.   EUROPEAN HEART JOURNAL

ABSORB Biodegradable Stents Versus Second-Generation Metal Stents

(2014) Alessio Mattesini et al.   JACC-Cardiovascular Interventions

Zastosowanie stentów bioresorbowalnych w leczeniu chorych ze stabilną dławicą piersiową oraz ostrymi zespołami wieńcowymi. Doświadczenia polskich ośrodków

(2014) Łukasz Rzeszutko et al.   Kardiologia Polska

Novel antiplatelet agents in acute coronary syndrome

(2014) Francesco Franchi et al.   Nature Reviews Cardiology

The Effects of Novel, Bioresorbable Scaffolds on Coronary Vascular Pathophysiology

(2014) Michael J. Lipinski et al.   Journal of Cardiovascular Translational Research

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

(2014) Patrick W. Serruys et al.   EuroIntervention

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

(2014) Yao-Jun Zhang et al.   EuroIntervention

Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold

(2013) Jens Wiebe et al.   Clinical Research in Cardiology

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

(2013) Michael Haude et al.   LANCET

Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)

(2013) Takashi Kajiya et al.   EuroIntervention

Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents

(2012) Soji Nishio et al.   CIRCULATION

The Disappearing Stent

(2012) Ron Waksman   CIRCULATION

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

(2012) John A. Ormiston et al.   Circulation-Cardiovascular Interventions

Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

(2012) Salvatore Brugaletta et al.   EUROPEAN HEART JOURNAL

Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial

(2011) Giovanna Sarno et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

(2011) Patrick W. Serruys et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

(2010) Patrick W. Serruys et al.   CIRCULATION

Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

(2010) Yoshinobu Onuma et al.   CIRCULATION

A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents

(2010) Josep Gomez-Lara et al.   JACC-Cardiovascular Interventions

Bioabsorbable Coronary Stents

(2009) John A. Ormiston et al.   Circulation-Cardiovascular Interventions

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

(2009) Patrick W Serruys et al.   LANCET